Clorox (NYSE:CLX) Given New $137.00 Price Target at Barclays

Clorox (NYSE:CLX) had its target price boosted by Barclays from $130.00 to $137.00 in a report published on Friday morning, Benzinga reports. They currently have an underweight rating on the stock.

CLX has been the topic of a number of other reports. Jefferies Financial Group raised Clorox from a hold rating to a buy rating and boosted their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price objective on Clorox from $148.00 to $174.00 and gave the company a neutral rating in a research note on Friday. BNP Paribas raised Clorox to a strong sell rating in a research note on Friday, September 6th. DA Davidson reissued a neutral rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the company a hold rating in a research note on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus price target of $150.14.

Clorox Trading Up 0.8 %

NYSE CLX opened at $161.59 on Friday. The business’s 50-day moving average price is $157.74 and its two-hundred day moving average price is $144.78. Clorox has a 12 month low of $114.68 and a 12 month high of $169.09. The firm has a market capitalization of $20.07 billion, a PE ratio of 83.73, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. On average, analysts expect that Clorox will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.02%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.51% of the company’s stock.

Institutional Trading of Clorox

Institutional investors and hedge funds have recently modified their holdings of the stock. GoalVest Advisory LLC bought a new position in shares of Clorox in the first quarter valued at approximately $31,000. First Foundation Advisors bought a new position in shares of Clorox in the first quarter valued at approximately $31,000. Innealta Capital LLC bought a new position in shares of Clorox in the second quarter valued at approximately $30,000. Trifecta Capital Advisors LLC grew its holdings in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. Finally, Quarry LP grew its holdings in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.